Angel Gambino is a keynote speaker, executive, advisor, and investor working at the intersection of AI, capital, and human potential, with deep work in behavioral science and mental health technology. She is Senior Advisor at PsyMed Ventures across frontier brain health, mental health, and behavioral health, where she focuses on fundraising and growth. Senior Advisor at Nfluence Partners, focused on mission-driven companies. Board Trustee at the California Institute of Integral Studies, where her focus is mission, and sustainability of mental health and wellbeing, consciousness, and psychedelic studies and research. Former CPO of Ellipsis Health (voice biomarkers for depression and anxiety), former CEO of Sensai, and founder of Angel Club (411 investors in the network, 8,000+ founders). 2026 keynote speaker at the ACA Angel Investing Summit and the EBAN Congress. Led BAFTA and BRIT award-winning teams at MTV Networks and the BBC.

Angel works at the operating intersection of behavioral science, AI policy, and mental health technology. As former Chief Product Officer of Ellipsis Health, she shipped voice biomarker AI for depression and anxiety screening that piloted with Cigna and Headspace, where the regulatory, clinical, and consumer questions were live at once. As Board Trustee at the California Institute of Integral Studies, she sits at an accredited graduate institution focused on mission, and sustainability of mental health and wellbeing, consciousness, and psychedelic studies and research. As Senior Advisor at PsyMed Ventures, she works across the frontier brain health, mental health, and behavioral health portfolio, focused on fundraising and growth. She co-convenes the Investor Jeffersonian Dinner Series on Human Centered AI at Human+Tech Week, off-the-record dinners for senior investors deploying into human-centered AI. Her Speaker page keynotes The body of the decision and Consciousness, AI, and the Frontier of Human Health are the public-facing version of this practice. She has advised 100+ mental health, behavioral health, and wellbeing companies.

Through her independent advisory practice and as Senior Advisor at PsyMed Ventures across frontier brain health, mental health, and behavioral health (focused on fundraising and growth), and at Nfluence Partners, an investment bank where she focuses on mission-driven companies, Angel leads growth, go-to-market, partnerships, capital formation, M&A, corporate development, ecosystem development, business development, and senior commercial leadership across early-stage founders, growth-stage C-suites, and large corporations. With early-stage founders, she also works on full-stack marketing, sales, scaling, and fundraising. She takes on selective Fractional Chief Growth Officer engagements at Series A+ companies, with particular depth in human-centered AI, mental health technology, and consumer health. She founded Angel Club, a private global membership community for angel-stage founders and investors. She serves as a Board Trustee at the California Institute of Integral Studies, where her focus is mission, and sustainability of mental health and wellbeing, consciousness, and psychedelic studies and research, and holds additional board seats, with capacity for additional paid director roles.

Through Angel Club’s syndicate. Every deal Angel makes or sources originates inside the Club, a private network of 8,000+ founders and 411 investors in the network. Allocators interested in deploying alongside her apply at angelclub.com/syndicate . Personal investments are made selectively, alongside an established lead.

Yes. Angel holds a small number of board seats and is selectively open to additional paid director roles where her experience as an executive, investor, and advisor across AI, capital formation, and growth aligns with the company’s stage and needs.

Angel is based between San Francisco, London, Milan, and Detroit. She travels internationally for keynotes, advisory engagements, and press.